GARDASIL 9


Pre-filled syringe 1
scheduling status
S2
registration number
51/30.1/0264
What GARDASIL 9 is and what it is used for
GARDASIL 9 is a vaccine (injection/shot) that helps protect against some diseases caused by some types of Human Papillomavirus (HPV). GARDASIL 9 contains the same 4 HPV types (6, 11, 16, 18) as in GARDASIL with 5 additional HPV types (31, 33, 45, 52, 58). In girls and women 9 years of age onward, GARDASIL 9 helps protect against: • Cervical (the lower end of the uterus or womb), vulvar (the outside of the female genitals), vaginal and anal cancer. • Pre-cancerous (changes in cells which have a risk of turning into cancer) cervical, vulvar (the outside of the female genitals), vaginal and anal lesions. • Genital warts. • HPV persistent infection. In boys and men 9 years of age onward, GARDASIL 9 helps protect against: • Anal cancer. • Pre-cancerous anal lesions. • Genital warts. • HPV persistent infection.
dosage
GARDASIL 9 should be administered intramuscularly as 3 separate 0,5 mL doses according to the following schedule: First dose: at elected date. Second dose: 2 months after the first dose. Third dose: 6 months after the first dose.
how to take
GARDASIL 9 is given as an injection usually in the arm muscle.
What GARDASIL 9 contains
Each 0,5 mL dose contains approximately 30 μg of HPV Type 6 L1 protein, 40 μg of HPV Type 11 L1 protein, 60 μg of HPV Type 16 L1 protein, 40 μg of HPV Type 18 L1 protein, 20 μg of HPV Type 31 L1 protein, 20 μg of HPV Type 33 L1 protein, 20 μg of HPV Type 45 L1 protein, 20 μg of HPV Type 52 L1 protein and 20 μg of HPV Type 58 L1 protein.
other ingredients
Each 0,5 mL dose of the vaccine also contains approximately 500 μg of aluminium (provided as AAHS), 9,56 mg of sodium chloride, 0,78 mg of L-histidine, 50 μg of polysorbate 80, 35 μg of sodium borate and water for injection. The product does not contain a preservative or antibiotics.
Therapeutic classification
A.30.1 Biologicals - Antigens.
© 2026 SAHPRA. ALL RIGHTS RESERVED